Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Industry News
Search Articles:
Xenon Pharmaceuticals advances second proprietary epilepsy product into the clinic
Xenon Pharmaceuticals announced initiation of a Phase 1 clinical trial of its proprietary epilepsy product candidate, XEN901, which is an orally administered, small molecule, highly selective Nav1.6 sodium channel inhibitor.
February 20, 2018
More...
Email This Page
to a Friend
Print This
Page